FdaApplication
BLA 125422
Identifiers
- fda_app_no: BLA125422
Properties
| Property | Value |
|---|---|
| applicant_name | ThromboGenics Inc. |
| application_type | BLA |
| approval_date | 2012-10-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JETREA | OCRIPLASMIN | 0.375MG/0.3ML (1.25MG/ML) | INJECTABLE;INTRAVITREAL |
| JETREA | — | 0.5MG/0.2ML (2.5MG/ML) | Injection |
2 products